Overview
Basic information
Litigation
Active legal matters
Material Events
8-K disclosures
SEC Filings
Key regulatory docs
Insider Transactions
Ownership changes
In Litigation
0
Settlement
Closed
1
Total Settlement
$1M
Critical Governance & Disclosure
Board, Voting & Shareholder Rights
Capital Structure & Financial Risk
Disclosure & Communications
Other definitive proxy statements
2026-10-22
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Statement of changes in beneficial ownership of securities
2026-09-29
Current report
2026-07-14
No Insider Transactions found for IGC Pharma, Inc.
TOP